Global Clinical Chemistry Market (2022 to 2027) – Basic Metabolic Panel Tests Segment Hold Lion’s Share – ResearchAndMarkets.com

Global Clinical Chemistry Market (2022 to 2027) – Basic Metabolic Panel Tests Segment Hold Lion’s Share – ResearchAndMarkets.com




Global Clinical Chemistry Market (2022 to 2027) – Basic Metabolic Panel Tests Segment Hold Lion’s Share – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Chemistry Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

Global clinical chemistry Market is anticipated to reach US$ 17.1 Billion by 2027. clinical chemistry products are used worldwide to test liquid samples, including plasma, blood, and urine, for the presence of any harmful drugs or drug-related chemicals.

Companies Mentioned

  • Abbott Laboratories
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Hitachi
  • HORIBA, Ltd.
  • Johnson & Johnson
  • Siemens Healthineers
  • Sysmex ADR
  • Thermo Fisher Scientific

Furthermore, general testing, special tests, diagnostic tests, toxicological tests, urinalysis, and clinical endocrinology tests are all included in clinical chemistry. Again, clinical chemistry tests are frequently used to diagnose chronic disorders such as diabetes and cancer. Clinical chemistry exams are often performed in other medical specialties like gynecology and cancer.

Worldwide Clinical Chemistry Market Size was US$ 13 Billion in 2021:

The rise of the clinical chemistry business has recently been fuelled by the rising prevalence of chronic ailments such as cancer and diabetes, which has resulted in greater demand for speedier diagnosis, technical breakthroughs, and scientific research for further therapeutic usage.

Effortless parameter monitoring, automatic data capture, and automatic variable changes are just a few of the advantages provided by the advancements. The total clinical chemistry market is predicted to grow in the future due to an increased desire for automated clinical chemistry techniques among healthcare and medical professionals. In addition, rising disposable incomes and increased awareness for the need of diagnostic examinations are driving demand in the clinical chemistry industry.

COVID-19 Impact on Global Clinical Chemistry Industry:

The COVID-19 epidemic harmed company sales around the world. Lockdowns stemming from the COVID-19 epidemic forced people to postpone medical appointments, reducing the number of tests performed and reagent sales. However, as governments increasingly relieve travel restrictions, there is a rebound in testing numbers.

Aside from vaccinations and therapeutic medications, there is an increasing market for developing more precise and straightforward testing methods and the expansion of testing structures. Companies have made strategic decisions to implement COVID-19 rapid tests, maintain revenue, and mitigate COVID-19’s impact on their operating capabilities. According to the publisher, Global clinical chemistry Industry is expected to expand with a CAGR of 4.7% during 2021-2027.

Reagents Segment will Gain Market Share during the Forecast Period:

The clinical chemistry market is divided into analyzers and reagents based on product. According to our analysis, the analyzer product segment is expected to contribute the most to the overall clinical chemistry market growth in the coming years since it is the first line of products utilized in several clinical chemistry tests. Despite this, the reagents sector would increase market share during the forecast period because of the high volume of reagents required compared to analyzers.

Basic Metabolic Panel Tests Segment Hold Lion’s Share:

By Test Type, we have covered the market for Basic Metabolic Panel, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Panel, and Specialty Chemical tests. According to our research, the basic metabolic panel tests category will account for most of the market in 2021. Furthermore, the rising incidence of diabetes and other lifestyle and chronic diseases and the growing trend of preventive healthcare can be ascribed to the growth of basic metabolic panel tests.

End-User, the Hospitals’ Segment dominates the Market:

Hospitals led the clinical chemistry industry in 2021, accounting for a significant market share. Increased market penetration and procedure volumes are to blame for hospital expansion worldwide. Expanded government programs to provide various services, such as funding for clinical chemistry, are another primary driver projected to drive the hospital industry. In addition, several hospitals work with laboratories to incorporate additional tests.

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

4.3 Opportunities

5. Global Clinical Chemistry Market

6. Market Share – Global Clinical Chemistry Market

6.1 By Product Type

6.2 By Test Type

6.3 By Technology

6.4 By End User

6.5 By Region

7. Product Type – Global Clinical Chemistry Market

7.1 Reagents

7.1.1 Small (400-800 Test/H)

7.1.2 Medium (800-1300 Tests/ H)

7.1.3 Large (1300-2000 Test/ H)

7.1.4 Very Large (2000 Test/H)

7.2 Analyzers

7.2.1 Liquid

7.2.2 Solid

7.2.3 Others

7.3 Others

8. Test Type – Global Clinical Chemistry Market

8.1 Basic Metabolic Panel

8.2 Electrolyte Panel

8.3 Liver Panel

8.4 Lipid Profile

8.5 Renal Profile

8.6 Thyroid Function Panel

8.7 Specialty Chemical tests

9. Technology – Global Clinical Chemistry Market

9.1 Semi-automated Clinical Chemistry

9.2 Fully Automated Clinical Chemistry

10. End User – Global Clinical Chemistry Market

10.1 Hospital

10.2 Academic Research Centers

10.3 Diagnostics Laboratories

10.4 Others

11. Region – Global Clinical Chemistry Market

11.1 North America

11.2 Europe

11.3 Asia Pacific

11.4 Middle East & Africa

11.5 Latin America

12. Porters Five Forces

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13. Company Analysis

For more information about this report visit https://www.researchandmarkets.com/r/dndp1v

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900